(Q60685651)
Statements
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up (English)
P Colombat
N Brousse
F Morschhauser
P Brice
E Deconinck
C Foussard
C Sebban
H Tilly
C Thieblemont
L Bergougnoux
F Lazreg
P Solal-Celigny